HER2DX Trademark
HER2DX is a USPTO trademark filed by REVEAL GENOMICS S.L.. Status: Registered.
Trademark Facts
| Mark | HER2DX |
|---|---|
| Serial Number | 79312395 |
| Registration Number | 6908909 |
| Status | Registered |
| Filing Date | 2021-03-19 |
| Registration Date | 2022-11-29 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals) |
| Owner | REVEAL GENOMICS S.L. |
| Attorney of Record | Donna A. Tobin |
| Prosecution Events | 42 |
| Latest Event | FINO on 2023-04-12 |
Goods & Services
Diagnostic preparations for scientific use; reagents for research purposes; reagents for medical research purposes; diagnostic reagents for scientific use or for research use; reagents for scientific use or for research use in the field of cancer; diagnostic reagents for clinical or medical laboratory use in the field of in vitro in biochemistry, clinical chemistry and microbiology | Products for medical diagnostics, namely, medical diagnostic reagents, medical diagnostic assays for testing body fluids and tissue, and specimen collection kits comprised of swabs for medical purposes and plastic bags for transmitting medical specimens, all for use in cancer detection; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; medical reagents for clinical use; medical diagnostic reagents for the analysis of body fluids and tissue; diagnostic reagents for use in diagnostic testing for medical purposes; diagnostic biomarker reagents for cancer diagnosis, prognosis and treatment for medical purposes; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of body fluids and tissue, and diagnostic reagents for medical use, all for cancer diagnosis, prognosis and treatment; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagents, namely, clinical medical reagents; diagnostic reagent kits consisting primarily of diagnostic reagents for medical use, in the field of cancer